Asset Planning Services (Pennsylvania)’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Asset Planning Services (Pennsylvania)’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-35	Closed	–	–	275
2019 Q3	$0	Hold	35	–	–	﹤0.01%	289
2019 Q2	$1K	Hold	35	–	–	﹤0.01%	258
2019 Q1	$1K	Hold	35	–	–	﹤0.01%	256
2018 Q4	$1K	Hold	35	–	–	﹤0.01%	260
2018 Q3	$2K	Hold	35	–	–	﹤0.01%	254
2018 Q2	$3K	Hold	35	–	–	﹤0.01%	243
2018 Q1	$2K	Hold	35	–	–	﹤0.01%	257
2017 Q4	$3K	Hold	35	–	–	﹤0.01%	254
2017 Q3	$4K	Buy	+35	New	+$3.68K	﹤0.01%	270

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Asset Planning Services (Pennsylvania)'s BLCM Position: Q4 2019 in Review

Asset Planning Services (Pennsylvania) sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2019, closing a stake of 35 shares.

Asset Planning Services (Pennsylvania) first reported a position in BLCM in Q3 2017 and held it in 9 quarters. The position peaked at $4K in Q3 2017. 51 funds tracked by Wall St. Rank hold BLCM as of Q4 2019.

Asset Planning Services (Pennsylvania) reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Asset Planning Services (Pennsylvania) sold 35 Bellicum Pharmaceuticals, Inc. shares in Q4 2019.
Asset Planning Services (Pennsylvania) first reported a position in Bellicum Pharmaceuticals, Inc. in Q3 2017 and held it in 9 quarters.
Asset Planning Services (Pennsylvania)'s Bellicum Pharmaceuticals, Inc. position peaked at $4K in Q3 2017.
51 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2019.

Based on Asset Planning Services (Pennsylvania)'s 13F filing for Q4 2019, filed 12 Feb 2020.